Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.10 | N/A | -48.19% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.10 | N/A | -48.19% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about future opportunities. They highlighted ongoing efforts to innovate and expand their market presence.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.
Penumbra's earnings report showed a significant miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, increasing by 2.58%, possibly due to management's optimistic outlook for long-term growth. Investors may be encouraged by the company's focus on innovation despite the current challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
TELADOC HEALTH INC
Feb 22, 2022